MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517048959 A) filed by Takeda Pharmaceutical Company Limited, Osaka, Japan, on May 21, for 'heterocyclic compound.'
Inventor(s) include Hattori, Yasushi; Pira, Marilena; Ito, Yoshiteru; Takeuchi, Kohei; Kimura, Eiji; Tokunaga, Norihito; Ikeda, Shuhei; Pawliczek, Martin Alexander; Tezuka, Noriyuki; Hoashi, Yasutaka; Miyanohana, Yuhei; Kajita, Yuichi; and Koike, Tatsuki.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy."
The patent application was internationally filed on Oct. 30, 2023, under International application No.PCT/IB2023/060928.
Disclaimer: Curated by HT Syndication.
